Korean Circ J.  2024 Jul;54(7):422-424. 10.4070/kcj.2024.0193.

Multidisciplinary Team Approach for the Management of Chronic Thromboembolic Pulmonary Hypertension

• Matsubara H

• KMID: 2557982
• DOI: http://doi.org/10.4070/kcj.2024.0193

Reference

1. Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021; 57:2002828. PMID: 33334946.

2. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369:319–329. PMID: 23883377.

3. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012; 5:748–755. PMID: 23192917.

4. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022; 43:3618–3731. PMID: 36017548.

5. Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013; 62:D92–D99. PMID: 24355646.

6. Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019; 53:1801915. PMID: 30545969.

7. Park TK, Chang S, Yang JH, et al. Programmed follow-up and quality control of treatment techniques enhance chronic thromboembolic pulmonary hypertension management: lessons from a multidisciplinary team. Korean Circ J. 2024; 54:409–421. PMID: 38956937.

8. Amsallem M, Guihaire J, Arthur Ataam J, et al. Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery. J Heart Lung Transplant. 2018; 37:1102–1110. PMID: 30037729.

9. Cannon JE, Su L, Kiely DG, et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation. 2016; 133:1761–1771. PMID: 27052413.